Vadadustat is an orally administered small molecule that inhibits hypoxia-inducible factor prolyl-hydroxylase (HIF-PH), thereby mimicking hypoxic conditions to stimulate erythropoiesis. It is used as an active pharmaceutical ingredient in the management of anemia associated with chronic kidney disease in adults on maintenance dialysis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Vadadustat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Cis-Etoposide
pharmaceutical raw material
Sulopenem etzadroxil
pharmaceutical raw material
Tegobuvir
pharmaceutical raw material
ARQ 197
pharmaceutical raw material
3-phenylpyridine
research compound
2-(pyridin-3-yl)benzoic acid
research compound
2-(Pyridin-3-yl)-5-(trifluoromethyl)benzenamine
Research reagent
4-(Pyridin-3-yl)phenylboronic acid
research compound
The international HS code for Vadadustat (CAS 1000025-07-9) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
JGRXMPYUTJLTKT-UHFFFAOYSA-N
C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O
Sourcing Vadadustat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.